M. L. Ancelin, S. Artero, F. Portet, A. M. Dupuy, J. Touchon et al., Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study, BMJ, vol.332, issue.7539, pp.455-459, 2006.
DOI : 10.1136/bmj.38740.439664.DE
URL : https://hal.archives-ouvertes.fr/inserm-00000025

P. K. Feyerabend, Problems of empiricism, 1981.
DOI : 10.1017/CBO9781139171588

P. B. Fontanarosa, D. Rennie, and C. D. Deangelis, Postmarketing Surveillance???Lack of Vigilance, Lack of Trust, JAMA, vol.292, issue.21, pp.2647-2650, 2004.
DOI : 10.1001/jama.292.21.2647

J. E. Graham and K. Ritchie, Mild Cognitive Impairment: Ethical Considerations for Nosological Flexibility in Human Kinds, Philosophy, Psychiatry, & Psychology, vol.13, issue.1
DOI : 10.1353/ppp.2006.0039

P. Kramer, Listening to Prozac, 1993.

B. Latour, The promises of constructivism, pp.27-46, 2003.
URL : https://hal.archives-ouvertes.fr/hal-01027765

. Wekstein, Neuropathologic substrate of mild cognitive impairment, Archives of Neurology, vol.63, pp.38-46, 2006.

R. C. Petersen, MCI is relevant: a response to Graham and Ritchie, Philosophy Psychiatry, & Psychology *, issue.*

B. M. Psaty and C. D. Furberg, COX-2 Inhibitors ??? Lessons in Drug Safety, New England Journal of Medicine, vol.352, issue.11, pp.1133-1135, 2005.
DOI : 10.1056/NEJMe058042

K. Ritchie, Mild cognitive impairment, Dialogues in Clinical Neuroscience, vol.6, pp.333-373, 2004.
DOI : 10.1201/b13196-46
URL : https://hal.archives-ouvertes.fr/inserm-00271473

S. *. Ticehurst, Mild Cognitive Impairment: Kinds, Ethics, and Market Forces, Philosophy, Psychiatry, & Psychology, vol.13, issue.1
DOI : 10.1353/ppp.2006.0048

C. Ritchie, P. Van-duijn, R. Visser, and . Petersen, Mild cognitive impairment -beyond controversies, towards a consensus Report of the International Working Group on Mild Cognitive Impairment, Journal of Internal Medicine, vol.256, pp.240-246, 2004.